Should You Buy Procore Technologies Inc (PCOR) Today? Analysis, Price Targets, and 2026 Outlook.
Conclusion
Sell
Latest Price
55.940
1 Day change
-1.50%
52 Week Range
88.920
Analysis Updated At
2026/01/30
PCOR is not a good buy right now. Despite being extremely oversold (RSI_6 ~12) and likely due for a technical bounce, the broader trend is decisively bearish (SMA_200 > SMA_20 > SMA_5 and a negatively expanding MACD histogram). With no proprietary buy signals today and statistically weak forward bias (notably negative 1-week/-1-month pattern projections), the higher-probability outcome for an impatient buyer is further downside or choppy action rather than a clean rebound you can confidently buy today.
Technical Analysis
Price/Trend: Pre-market ~56.34 (-0.79%) sits below S1 (58.37) and is hovering closer to S2 (54.43), indicating the stock has already broken an important support zone and is probing the next support.
Momentum: MACD histogram -1.088 and negatively expanding = downside momentum is still accelerating.
Overbought/Oversold: RSI_6 at 12.07 = deeply oversold, which increases odds of a short-term snapback, but oversold alone is not a buy signal when trend/momentum are still deteriorating.
Moving Averages: Bearish stack (SMA_200 > SMA_20 > SMA_5) confirms a persistent downtrend.
Key Levels: Support ~54.43 (S2). Near-term resistance ~58.37 (S1) then ~64.74 (pivot). For a higher-quality entry, price should reclaim and hold at least S1/pivot with improving momentum.
**Intellectia Proprietary Trading Signals**
- [AI Stock Picker](module://ai_stock_pick): no signal on given stock today.
- [SwingMax](module://swingmax): No signal on given stock recently.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Sentiment/Positioning: Options positioning is extremely call-heavy (OI put-call 0.13; volume put-call 0.01), which reads as bullish/speculative sentiment.
Activity: Today’s options volume (~1,988) is elevated versus recent averages (vs 30-day avg ~85.99%), and open interest is also elevated (today vs OI avg ~126.2%), suggesting active positioning.
Volatility: 30D IV ~40.28 vs HV ~50.61, and IV percentile ~42 (IV rank ~7) implies IV is not stretched; options are not pricing an extreme near-term move versus the stock’s realized volatility.
Takeaway: Options traders are leaning bullish, but that has not yet translated into price stabilization—this looks more like dip-buying/speculation than confirmed reversal.
Technical Summary
Sell
9
Buy
6
Positive Catalysts
on 2026-02-12 after hours could act as a catalyst if guidance/margins surprise positively.
Neutral/Negative Catalysts
Technical breakdown: trading below S1 with bearish MA stack and worsening MACD increases risk of continued drift toward/through S2 (~54.43).
Pattern-based forward view provided: higher probability of weakness over 1-week (-2.69%) and 1-month (-9.95%) horizons.
Earnings risk on 2026-02-12: with the stock already weak, any miss or cautious guidance could accelerate downside.
Profitability still not established (latest quarter remains loss-making), which can be punished in risk-off tape (S&P500 pre-market -0.39%).
Financial Performance
Latest reported quarter: 2025/Q3.
Growth: Revenue 338.851M, +14.52% YoY (solid top-line growth).
Profitability: Net income -9.101M (more negative YoY, -65.51%); EPS -0.06 (worse YoY, -66.67%).
Margins: Gross margin 79.71%, down ~2.11% YoY.
Read-through: The company is still growing well, but profitability and gross margin weakened in the latest quarter—fundamentals don’t currently provide a clean ‘buy-the-dip’ justification while the chart is breaking down.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend: Analyst stance has strengthened meaningfully with multiple price-target increases and upbeat reiterations following Q3, plus a notable upgrade.
Key changes: Barclays upgraded to Overweight (2026-01-05) with PT $90 (from $82). BTIG initiated Buy with PT $88 (2025-12-16). Several firms raised PTs on 2025-11-06 (Baird $93, Piper $91, Canaccord $90, TD Cowen $90, BMO $87, Stifel $85) while maintaining bullish ratings.
Wall Street pros: improving GTM execution, strong large-deal traction, margin expansion trajectory, and potential multi-year demand tailwind as construction improves post-rate cuts.
Wall Street cons: at least some tempering around the pace of 2026 acceleration (e.g., Canaccord), and the stock’s current price action is not confirming the bullish thesis yet.
Influential/Political flows: No recent congress trading data available; hedge funds and insiders show neutral recent trends.
Wall Street analysts forecast PCOR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PCOR is 87.83 USD with a low forecast of 70 USD and a high forecast of 95 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
15 Analyst Rating
Wall Street analysts forecast PCOR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PCOR is 87.83 USD with a low forecast of 70 USD and a high forecast of 95 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
13 Buy
2 Hold
0 Sell
Strong Buy
Current: 56.790
Low
70
Averages
87.83
High
95
Current: 56.790
Low
70
Averages
87.83
High
95
Barclays
Equal Weight -> Overweight
upgrade
$82 -> $90
AI Analysis
2026-01-05
Reason
Barclays
Price Target
$82 -> $90
AI Analysis
2026-01-05
upgrade
Equal Weight -> Overweight
Reason
Barclays upgraded Procore to Overweight from Equal Weight with a price target of $90, up from $82. The firm says non-residential construction usually improves two years after rate cuts, which points to improvement in fiscal 2026. Meanwhile, Procore's new CEO has driven wallet share in enterprise, the analyst tells investors in a research note. Barclays believes the company could compound growth at 15% through fiscal 2027.
BTIG
Nick Altmann
Buy
initiated
$88
2025-12-16
Reason
BTIG
Nick Altmann
Price Target
$88
2025-12-16
initiated
Buy
Reason
BTIG analyst Nick Altmann initiated coverage of Procore with a Buy rating and $88 price target.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for PCOR
